| ACTUATE THERAPEUTICS, INC. | ACTU | Martin H. Huber Jr.DirDERIV | May 21 | A | 15,000 | $0.00 | —? |
| Syndax Pharmaceuticals Inc | SNDX | Martin H. Huber Jr.Dir | Feb 4 | A | 24,000 | $0.00 | — |
| Mersana Therapeutics, Inc. | MRSN | Martin H. Huber Jr.CEODERIV | Jan 6 | D | 7,256 | — | — |
| Mersana Therapeutics, Inc. | MRSN | Martin H. Huber Jr.CEODERIV | Jan 6 | D | 1,328 | — | — |
| Mersana Therapeutics, Inc. | MRSN | Martin H. Huber Jr.CEODERIV | Jan 6 | D | 13,340 | — | — |
| Mersana Therapeutics, Inc. | MRSN | Martin H. Huber Jr.CEODERIV | Jan 6 | D | 7,467 | — | — |
| Mersana Therapeutics, Inc. | MRSN | Martin H. Huber Jr.CEODERIV | Jan 6 | D | 497 | — | — |
| Mersana Therapeutics, Inc. | MRSN | Martin H. Huber Jr.CEODERIV | Jan 6 | D | 364 | — | — |
| Mersana Therapeutics, Inc. | MRSN | Martin H. Huber Jr.CEODERIV | Jan 6 | D | 27,878 | — | — |
| Mersana Therapeutics, Inc. | MRSN | Martin H. Huber Jr.CEODERIV | Jan 6 | D | 12,121 | — | — |
| Mersana Therapeutics, Inc. | MRSN | Martin H. Huber Jr.CEODERIV | Jan 6 | D | 179 | — | — |
| Mersana Therapeutics, Inc. | MRSN | Martin H. Huber Jr.CEODERIV | Jan 6 | D | 734 | — | — |
| Mersana Therapeutics, Inc. | MRSN | Martin H. Huber Jr.CEODERIV | Jan 6 | D | 135 | — | — |
| Mersana Therapeutics, Inc. | MRSN | Martin H. Huber Jr.CEODERIV | Jan 6 | D | 1,800 | — | — |
| Mersana Therapeutics, Inc. | MRSN | Martin H. Huber Jr.CEODERIV | Jan 6 | D | 407 | — | — |
| Mersana Therapeutics, Inc. | MRSN | Martin H. Huber Jr.CEODERIV | Jan 6 | D | 1,002 | — | — |
| Mersana Therapeutics, Inc. | MRSN | Martin H. Huber Jr.CEODERIV | Jan 6 | D | 99 | — | — |
| Mersana Therapeutics, Inc. | MRSN | Martin H. Huber Jr.CEODERIV | Jan 6 | D | 1,923 | — | — |
| Mersana Therapeutics, Inc. | MRSN | Martin H. Huber Jr.CEODERIV | Jan 6 | D | 26,713 | — | — |
| Mersana Therapeutics, Inc. | MRSN | Martin H. Huber Jr.CEODERIV | Jan 6 | D | 5,938 | — | — |
| Mersana Therapeutics, Inc. | MRSN | Martin H. Huber Jr.CEO | Jan 6 | U | 9,573 | — | — |